Concepedia

Meri Ramela

MR

Statistics

Publications

6

Citations

138

H-Index

6

Active since

2006

Affiliations

Orion Corporation (Finland)(Current)

Helsinki University Hospital

University of Zurich

Meri Ramela is an author at Orion Corporation (Finland) specializing in pharmacology, pharmacokinetics, and medicine.

ORCID

Publications per year

2006–2022

6

Publications

6

Pharmacokinetics of Intravenous Levosimendan and Its Metabolites in Subjects With Hepatic Impairment

Jaakko Puttonen, Sampo Kantele, A. Rück et al. · The Journal of Clinical Pharmacology · 2008 · 40 citations

, , +14

First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis

Mari Karimaa, Reetta Riikonen, Henna Kettunen et al. · Molecular Cancer Therapeutics · 2022 · 24 citations · Full text

, , +17

Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1

Riikka Oksala, Anu Moilanen, Reetta Riikonen et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2018 · 22 citations · Full text

, , +17

Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men

Jaakko Puttonen, Tarmo Laine, Meri Ramela et al. · European Journal of Pharmaceutical Sciences · 2007 · 21 citations

, , +9

Comparison of cardiopulmonary effects of dexmedetomidine administered as a constant rate infusion without loading dose in sheep and goats anaesthetised with sevoflurane

Sabine Kästner, Jolanda Boller, Annette P. N. Kutter et al. · Small Ruminant Research · 2006 · 20 citations

, , +12

1–5 of 6